A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 2 Proof-of-Concept Study to Evaluate Safety, Tolerability, and Efficacy of GS-9876 in Subjects With Active Rheumatoid Arthritis on Background Therapy With Methotrexate
收藏DataCite Commons2024-12-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00008706/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The primary objective of this study is to evaluate the effect of GS-9876 versus placebo for
the treatment of signs and symptoms of rheumatoid arthritis (RA) in participants with active
RA as measured by change from baseline in Disease Activity Score for 28 joint count using
C-reactive protein (CRP) (DAS28 (CRP)) at Week 12.
提供机构：
Vivli
创建时间：
2023-01-03
